微创系今早(14日)全线上扬，其中微创脑科学(02172.HK) 升幅最多，该股今日高开6.43%，最高见13.78元。现报13.14元，升20.77%，成交1,761.7万股，涉资2.28亿元。
微创医疗(00853.HK) 今日高开1.16%，最高见9.09元。现报8.81元，升13.68%，成交3,684.11万股，涉资3.19亿元。
微创机器人-B(02252.HK) 今日高开0.49%，最高见21.6元。现报20.75元，升2.22%，成交431万股，涉资9,010.34万元。
心通医疗-B(02160.HK) 今日低开1.82%，最低见1.08元。现报1.13元，升2.73%，成交196.5万股，涉资220.56万元。
摩通早前发表研报指，微创机器人的订单趋势强劲，亦属微创医疗旗下重要的子公司，预料由于中国和海外机器人安装的快速扩张，前者对集团销售贡献将由2024年约3%升至2033年约40%。该行亦重申，对微创医疗持积极看法，形容在中小型医疗技术领域(SMID)中，集团是多元化本地领导者，具有强大的创新能力、海外市场扩张，并且预计至2026年可扭亏为盈；又指集团仍然是该行在SMID医疗技术领域的首选。(js/a)(港股报价延迟最少十五分钟。沽空资料截至 2025-03-13 16:25。)
相关内容《盈警》微创医疗(00853.HK)估计全年亏损不超过2.75亿美元 大减58%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.